Caxton Associates (UK)’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.72M Buy
+3,554
New +$943K 0.03% 295
2026
Q1
Sell
-1,480
Closed -$246K 1039
2025
Q4
$246K Buy
+1,480
New +$248K ﹤0.01% 664
2025
Q3
Sell
-163,753
Closed -$14.8M 965
2025
Q2
$14.8M Buy
+163,753
New +$12.9M 0.38% 36

Other funds holding ALAB

Caxton Associates (UK)'s ALAB Position: Q2 2026 in Review

Caxton Associates (UK) opened a new position in Astera Labs (ALAB) in Q2 2026: 3,554 shares worth $1.72M. The stake represents 0.03% of the portfolio and ranks #295 among its holdings. This is a return to the name: Caxton Associates (UK) previously reported a position in ALAB as recently as Q4 2025.

Caxton Associates (UK) first reported a position in ALAB in Q2 2025 and has held it in 3 quarters since. The position peaked at $14.8M in Q2 2025. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Caxton Associates (UK) held 3,554 shares of Astera Labs worth $1.72M as of Q2 2026.
  • Astera Labs was a new Caxton Associates (UK) position in Q2 2026.
  • Astera Labs made up 0.03% of Caxton Associates (UK)'s portfolio in Q2 2026, its #295 holding.
  • Caxton Associates (UK) first reported a position in Astera Labs in Q2 2025 and has held it in 3 quarters since.
  • Caxton Associates (UK)'s Astera Labs position peaked at $14.8M in Q2 2025.
  • 989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.